HMM1-022

· Humedix Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HMM1-022, covering 2025-12-11 to 2025-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet [NA]